The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Gastrointestinal stromal tumors (GIST) of the duodenum: A French Sarcoma Group (FSG) retrospective review of 90 patients (pts).
F. Duffaud
Honoraria - Novartis; Pfizer
I. L. Ray-Coquard
No relevant relationships to disclose
A. Blesius
No relevant relationships to disclose
T. K. Huynh
No relevant relationships to disclose
E. Boucher
Consultant or Advisory Role - Merck
O. Bouche
Honoraria - Novartis
J. Bay
No relevant relationships to disclose
F. Marchal
No relevant relationships to disclose
J. Spano
Honoraria - GlaxoSmithKline; Merck; Roche
F. Bertucci
No relevant relationships to disclose
B. Bui Nguyen
Honoraria - PharmaMar
O. Collard
No relevant relationships to disclose
L. Chaigneau
No relevant relationships to disclose
N. Isambert
Honoraria - PharmaMar
A. Adenis
Honoraria - Novartis; Pfizer
J. Mancini
No relevant relationships to disclose
A. Le Cesne
Consultant or Advisory Role - Novartis; Pfizer; PharmaMar
Honoraria - Novartis; Pfizer; PharmaMar
J. Blay
Consultant or Advisory Role - Novartis; Pfizer; PharmaMar
Honoraria - Novartis; PharmaMar